Overview
Tatjana Zablocka practices practicing medicine in Riga, Latvia.
Her clinical expertise encompasses Melanoma, Plasmacytoma, Breast Enlargement In Males, and ECHO Virus.
She is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Tatjana Zablocka
Is Tatjana Zablocka a top-rated expert for Melanoma?
MediFind is an objective health platform that identifies experts based on real-world data. Tatjana Zablocka is classified as an Experienced expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Tatjana Zablocka participate in research or clinical trials?
Yes. Tatjana Zablocka has published 9 articles and abstracts on conditions like Melanoma. You can view a list of Tatjana Zablocka's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast Enlargement In MalesMs. Zablocka isExperienced. Learn about Breast Enlargement In Males.
- ECHO VirusMs. Zablocka isExperienced. Learn about ECHO Virus.
- MelanomaMs. Zablocka isExperienced. Learn about Melanoma.
- PlasmacytomaMs. Zablocka isExperienced. Learn about Plasmacytoma.